Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Health World Trade Corporation was a wholly-owned subsidiary of China Holdings, Inc. (formerly China Health Holding, Inc.), a development-stage company focused on the pharmaceutical and dietary supplement markets in China. Established in the mid-2000s, the company was tasked with developing a retail and franchise infrastructure to support the worldwide branding and multi-channel distribution of Traditional Chinese Medicine (TCM) products. Its portfolio was intended to leverage proprietary natural herbal medicinal formulas, including the 'King of Herbs' and 'Taoist Medicinal' product lines. However, the parent company pivoted its business focus toward renewable energy projects, such as wind and biomass power, around 2008, leading to the cessation of its healthcare-related operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Health World Trade.